Back to search

Peptide record

TPDB26839

Antibacterial Anticancer Toxicity modified_plain modified
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB26839
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 19-aa modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
XKPRXYTPRPTSHPRPIRV
Physicochemical Analysis
C92H152N32O22
ANDCEQGLMFW
P
2058.42
12.41
6
0
3
+5
6.67
-1.468
35.79
Mammalian: Yeast: E.coli:
1490
72.39
4
Residue Composition
number
0
A
4
R
0
N
0
D
0
C
0
E
0
Q
0
G
1
H
1
I
0
L
1
K
0
M
0
F
5
P
1
S
2
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 1 L: 0 K: 1 M: 0 F: 0 P: 5 S: 1 T: 2 W: 0 Y: 1 V: 1
Chemical Descriptors
19
C92H152N32O22
2058.42
12.41
+5
6.67
-1.468
Evidence Records 2 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity. | Protein Pept Lett | 2014
Evidence 2 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity. | Protein Pept Lett | 2014